dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination has been researched along with Infantile Respiratory Distress Syndrome in 106 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (1.89) | 18.7374 |
1990's | 88 (83.02) | 18.2507 |
2000's | 13 (12.26) | 29.6817 |
2010's | 3 (2.83) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, HY; Han, D; Jiang, H; Wu, HM; Wu, S; Yuan, LJ; Zhang, L; Zhao, S | 1 |
Lal, MK; Sinha, SK | 1 |
Moya, F | 1 |
Carlos, RQ; Davonzo, C; Dimaguila, MA; Gal, P; McPherson, C; Ransom, JL; Smith, M; Wimmer, JE | 1 |
Bahadue, FL; Soll, R | 1 |
Carlo, WA; St John, EB | 1 |
Bevilacqua, G; Parmigiani, S | 1 |
Bhutani, VK; Bowen, FW; Sivieri, EM | 1 |
Georgiev, GA; Georgieva, R; Iordanova, A; Khristova, E; Lalchev, Z; Petkova, Kh; Stoimenova, E; Todorov, R; Vasiliev, Kh | 1 |
Halliday, HL | 1 |
Easa, D; Long, W; Mullett, M; Schumacher, R; Sundell, H; Walther, FJ | 1 |
Cotton, R; Guthrie, R; Hirata, T; LeBlanc, M; Long, W; Mammel, M; Sell, M | 1 |
Beaumont, E; Cook, L; Dhanireddy, R; Gerdes, J; Gerdes, M; Jarret, R; Kopleman, A; Long, W | 1 |
Asbill, D; Bose, CL; Corbet, AJ; Edwards, K; Garcia-Prats, J; Kraybill, EN; Long, W | 1 |
Bard, H; Conway, B; Courtney, SE; Long, W; McMillan, D; Sauve, R; Thompson, T; Walter, D | 1 |
Corbet, A; Cotton, R; Gerdes, J; Long, W; Schumacher, R | 1 |
Bingham, W; Casiro, O; Long, W; MacMurray, B; Saigal, S; Vincer, M; Whitfield, M | 1 |
Bingham, W; Casiro, O; Long, W; MacMurray, B; Robertson, C; Saigal, S; Sankaran, K; Whitfield, M | 1 |
Anday, E; Boros, S; Bucciarelli, R; Burchfield, D; Gong, A; Long, W; Zucker, J | 1 |
Bard, H; Derleth, D; Long, W; Pauly, T; Robertson, C; Sauve, R; Stevenson, D; Vincer, M | 1 |
Allen, A; Long, W; MacMurray, B; Peliowski, A; Sankaran, K; Shukla, A; Smyth, J; Volberg, F | 1 |
Bard, H; Chernick, V; Finer, N; Krzeski, R; Long, W; McMillan, D; Schiff, D; Watts, J | 1 |
Avila, E; Cook, L; Corbet, A; Edwards, K; Gerdes, J; Long, W; Puri, A; Rosenberg, A | 1 |
Hamdan, AH; Shaw, NJ | 2 |
Laugier, J; Nashashibi, M; Nasr, C; Saliba, E; Vaillant, MC | 1 |
Kääpä, P; Kero, P; Seppänen, M | 1 |
Klein, JM; Patel, CA | 1 |
Bernstein, G; Cleary, JP; Heldt, GP; Mannino, FL | 1 |
Fuhrman, BP; Hernan, LJ; Holm, B; Leach, CL; Morin, FC; Papo, MC; Steinhorn, D | 1 |
Apere, H; Choukroun, ML; Demarquez, JL; Fayon, M; Galperine, RI; Guenard, H; Llanas, B | 1 |
Billman, D; Nicks, J; Schumacher, R | 1 |
Buck, R; Garland, J; Weinberg, M | 1 |
Soll, RF; Tarnow-Mordi, WO | 1 |
Cheah, IG; Lim, NL; Nordin, MM | 1 |
Gore, SM | 1 |
Robertson, B; Speer, CP | 1 |
Morley, C | 1 |
Tarnow-Mordi, W | 1 |
Hoffman, DR; Johnston, JM; Moya, FR; Zhao, B | 1 |
Glover, RM; Laing, IA; Parry, GJ; Stenson, BJ; Tarnow-Mordi, WO; Wilkie, RA | 1 |
Corkey, C; Jenkins, J; Rollins, M; Tubman, R; Wilson, D | 1 |
Ewing, CK; Richards, T; Sehgal, SS; Taeusch, HW | 1 |
Bourchier, D; Broadbent, R; Darlow, B; Knight, D; Selby, R; Wach, R | 1 |
Chan, JO; Darrow, KA; Kim, AH; Marks, KH; Moglia, BA; Reeves, IV; Seaton, JF | 1 |
Robertson, B; Sangstad, OD | 1 |
Bauer, CR; Fanaroff, AA; Fletcher, BD; Horbar, JD; Korones, SB; Oh, W; Shankaran, S; Soll, RF; Wright, EC; Wright, LL | 1 |
Phibbs, CS; Phibbs, RH; Schlueter, MA; Sniderman, S; Tooley, WH; Wakeley, A | 1 |
Bratlid, D; Farstad, T | 1 |
Abbasi, S; Bhutani, VK; Gerdes, JS | 1 |
Agarwal, R; Alba, J; Hegyi, T; Hiatt, IM | 1 |
Clarke, MP; Fritz, S; Pennefather, PM; Strong, NP; Tin, W | 1 |
Ishisaka, DY | 1 |
Claris, O; Grandjean, H; Hascoët, JM; Lenoir, S | 1 |
Auten, RL; Balsan, MJ; Belcastro, MR; Brody, AS; Buckwald, S; Carrion, V; Donohue, PK; Durand, DJ; Egan, EA; Farrell, EE; Graeber, JE; Horgan, MJ; Hudak, ML; Jansen, RD; Jung, AL; Laskay, KM; Maniscalco, WW; Martin, DJ; Matteson, EJ; Miller, RR; Montgomery, P; Riddlesberger, MM; Rosenberg, AA; Torres, BA | 1 |
Rogers, D | 1 |
Jeffery, HE; Skelton, R | 1 |
Bassiouny, MR; Cherian, E; Remo, C | 1 |
Santeiro, ML; Wyble, L | 1 |
Asselin, JM; Auten, RL; Belcastro, MR; Brody, AS; Cummings, NJ; Donohue, PK; Egan, EA; Hamm, CR; Hudak, ML; Jansen, RD; Jung, AL; Kimberlin, LV; Martin, DJ; Matteson, EJ; Montgomery, P; Riddlesberger, MM; Rosenberg, AA | 1 |
Cotton, RB; Lindstrom, DP; Parker, RA; Sandberg, KL; Sjöqvist, BA | 1 |
al-Essa, M; Dolovich, M; Fok, TF; Kirpalani, H; Rasid, F | 1 |
Kempley, ST; Murdoch, E | 2 |
John, E; Lloyd, J; Todd, DA | 1 |
Merchant, RH; Sanghvi, KP | 1 |
Al Khusaiby, SM; da Costa, DE; Pai, MG | 1 |
Soll, RF | 1 |
Beghetti, M; Berner, M; Hanquinet, S; Rimensberger, PC | 1 |
Halliday, HL; Robertson, B; Speer, CP | 1 |
Fellman, V; Ikonen, S; Järvenpää, AL; Kukkonen, AK; Pokela, ML; Virtanen, M | 1 |
Soll, RF; Suresh, GK | 1 |
Christodoulaki, M; Giannakopoulou, C; Hatzidaki, E; Korakaki, E; Mamoulakis, D; Margari, KM | 1 |
Galan, HL; Kuehl, TJ | 1 |
Balaraman, V; Barrett, J; Easa, D; Ibarra-Pratt, E; Loo, SW; Nakamura, KT; Pelke, S; Smith, MB | 1 |
Ariagno, RL; Armsby, DH; Baldwin, R; Bellon, G; Carlisle, K; Long, W; Rector, D; Stevenson, DK | 1 |
King, M; Ramirez, O; Rubin, BK | 1 |
Bhatt-Mehta, V; Schumacher, RE | 1 |
Cummings, JJ; Egan, EA; Ferguson, WH; Holm, BA; Hudak, BB; Hudak, ML | 1 |
Ashton, MR; Austin, NC; Hall, MA; Normand, IC; Postle, AD; Smith, DE | 1 |
Sekar, KC; Toubas, PL; Wallenbrock, MA | 1 |
Bose, G | 1 |
Dechant, KL; Faulds, D | 1 |
Abbasi, S; Bhutani, VK; Gerdes, JS; Long, WA | 1 |
Anday, E; Easa, D; Gong, A; LeBlanc, M; Long, W; Pauly, T; Pramanik, A; Sell, M; Stevenson, D; Walther, F | 1 |
Bard, H; Bourgeois, M; Chessex, P; Hazan, J; Long, W; Piedboeuf, B | 1 |
Gerdes, J; Long, W; Whitsett, J | 1 |
Derleth, D; Finer, N; Long, W; McMurray, B; Mullett, M; Peliowski, A; Sankaran, K; van Houten, J; Walker, D; Wold, D | 1 |
Prevost, RR | 1 |
Edwards, DK; Levine, D; Merritt, TA | 1 |
Bard, H; Chernick, V; Corbet, A; Cotton, R; Courtney, S; Long, W; McGuiness, G; Smyth, J; Walter, D; Watts, J | 1 |
Corbet, AJ; Garcia-Prats, JA; Lombardy, LR; Long, WA; Murphy, DJ; Wold, DE | 1 |
Bucciarelli, R; Corbet, A; Goldman, S; Long, W; Mammel, M; Wold, D | 1 |
Ma, EJ; van de Bor, M; Walther, FJ | 1 |
Guthrie, R; Long, W; Schumacher, R; Sundell, H; Thompson, T; Volberg, F | 1 |
Nightingale, SL | 1 |
Bose, C; Bose, G; Corbet, A; Donlon, D; Garcia-Prats, J; Lombardy, L; Long, W; Wold, D | 1 |
Brown, CL; Clements, JA; Muramatsu, K; Schlueter, MA; Tooley, WH | 1 |
Ballard, P; Clements, JA; Clyman, RI; Durand, DJ; Heymann, MA; Kitterman, J; Mauray, F | 1 |
10 review(s) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Infantile Respiratory Distress Syndrome
Article | Year |
---|---|
Effect of exogenous pulmonary surfactants on mortality rate in neonatal respiratory distress syndrome: A network meta-analysis of randomized controlled trials.
Topics: Biological Products; Drug Combinations; Fatty Alcohols; Humans; Phosphatidylglycerols; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Proteins; Pulmonary Surfactants; Randomized Controlled Trials as Topic; Respiratory Distress Syndrome, Newborn | 2015 |
Surfactant respiratory therapy using Surfaxin/sinapultide.
Topics: Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Peptides; Phosphatidylglycerols; Phosphorylcholine; Polyethylene Glycols; Polymyxin B; Proteins; Pulmonary Surfactants; Randomized Controlled Trials as Topic; Respiratory Distress Syndrome, Newborn; Treatment Outcome | 2008 |
Synthetic surfactants: where are we? Evidence from randomized, controlled clinical trials.
Topics: Animals; Biological Products; Bronchopulmonary Dysplasia; Dose-Response Relationship, Drug; Drug Combinations; Evidence-Based Medicine; Fatty Alcohols; Follow-Up Studies; Humans; Infant, Newborn; Intensive Care, Neonatal; Phosphatidylglycerols; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Proteins; Pulmonary Surfactant-Associated Proteins; Pulmonary Surfactants; Randomized Controlled Trials as Topic; Respiratory Distress Syndrome, Newborn; Survival Rate; Treatment Outcome | 2009 |
Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
Topics: Acute Disease; Acute Lung Injury; Chronic Disease; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Lung Diseases; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Randomized Controlled Trials as Topic; Respiratory Distress Syndrome, Newborn; Time Factors | 2012 |
Overview of clinical trials comparing natural and synthetic surfactants.
Topics: Biological Products; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Randomized Controlled Trials as Topic; Respiratory Distress Syndrome, Newborn | 1995 |
Artificial versus natural surfactant--can we base clinical practice on a firm scientific footing?
Topics: Biological Products; Clinical Trials as Topic; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1994 |
Exogenous surfactant use in neonates.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Biological Products; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1996 |
Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome.
Topics: Biological Products; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Infant, Premature; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 2000 |
Delayed compliance increase in infants with respiratory distress syndrome following synthetic surfactant.
Topics: Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Humans; Infant, Newborn; Lung Compliance; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Gas Exchange; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Time Factors | 1992 |
Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Double-Blind Method; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1991 |
68 trial(s) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Infantile Respiratory Distress Syndrome
Article | Year |
---|---|
Postnatal changes in pulmonary mechanics and energetics of infants with respiratory distress syndrome following surfactant treatment.
Topics: Continuous Positive Airway Pressure; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Infant, Premature; Longitudinal Studies; Oxygen; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Respiratory Function Tests; Retrospective Studies | 2005 |
One-year follow-up of 66 premature infants weighing 500 to 699 grams treated with a single dose of synthetic surfactant or air placebo at birth: results of a double-blind trial. American Exosurf Neonatal Study Group I.
Topics: Air; Child Development; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Hospitalization; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Lung Diseases; Male; Neurologic Examination; Phosphorylcholine; Polyethylene Glycols; Psychomotor Performance; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Retinopathy of Prematurity | 1995 |
One-year follow-up of 273 infants with birth weights of 700 to 1100 grams after prophylactic treatment of respiratory distress syndrome with synthetic surfactant or air placebo. American Exosurf Neonatal Study Group I.
Topics: Air; Child Development; Chronic Disease; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Health Status; Hospitalization; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Lung Diseases; Male; Neurologic Examination; Phosphorylcholine; Polyethylene Glycols; Psychomotor Performance; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Retinopathy of Prematurity | 1995 |
Health and neurodevelopmental outcome at 1-year adjusted age in 508 infants weighing 700 to 1100 grams who received prophylaxis with one versus three doses of synthetic surfactant. American Exosurf Neonatal Study Groups I and II.
Topics: Child Development; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Health Status; Humans; Infant Mortality; Infant, Low Birth Weight; Infant, Newborn; Lung Diseases; Male; Nervous System Diseases; Neurologic Examination; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Retinopathy of Prematurity | 1995 |
Double-blind evaluation of developmental and health status to age 2 years of infants weighing 700 to 1350 grams treated prophylactically at birth with a single dose of synthetic surfactant or air placebo.
Topics: Air; Child Development; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Health Status; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Male; Nervous System Diseases; Neurologic Examination; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Psychomotor Performance; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Retinopathy of Prematurity | 1995 |
Double-blind 1-year follow-up of 1540 infants with respiratory distress syndrome randomized to rescue treatment with two doses of synthetic surfactant or air in four clinical trials. American and Canadian Exosurf Neonatal Study Groups.
Topics: Air; Birth Weight; Child Development; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Health Status; Humans; Infant, Newborn; Male; Nervous System Diseases; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Psychomotor Performance; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Retinopathy of Prematurity | 1995 |
Double-blind developmental evaluation at 1-year corrected age of 597 premature infants with birth weights from 500 to 1350 grams enrolled in three placebo-controlled trials of prophylactic synthetic surfactant. American Exosurf Neonatal Study Group I.
Topics: Air; Child Development; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Male; Neurologic Examination; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Psychomotor Performance; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Retinopathy of Prematurity | 1995 |
One-year follow-up of 89 infants with birth weights of 500 to 749 grams and respiratory distress syndrome randomized to two rescue doses of synthetic surfactant or air placebo. Canadian Exosurf Neonatal Study Group. Canadian Exosurf Neonatal Follow-Up Gro
Topics: Air; Child Development; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Health Status; Humans; Infant, Low Birth Weight; Infant, Newborn; Male; Nervous System Diseases; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Psychomotor Performance; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Retinopathy of Prematurity | 1995 |
One-year outcome in 232 premature infants with birth weights of 750 to 1249 grams and respiratory distress syndrome randomized to rescue treatment with two doses of synthetic surfactant or air placebo. Canadian Exosurf Neonatal Study Group.
Topics: Air; Child Development; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Health Status; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Male; Nervous System Diseases; Phosphorylcholine; Polyethylene Glycols; Psychomotor Performance; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Retinopathy of Prematurity | 1995 |
One-year follow-up evaluation of 260 premature infants with respiratory distress syndrome and birth weights of 700 to 1350 grams randomized to two rescue doses of synthetic surfactant or air placebo. American Exosurf Neonatal Study Group I.
Topics: Air; Child Development; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Hospitalization; Humans; Infant, Low Birth Weight; Infant, Newborn; Lung Diseases; Male; Nervous System Diseases; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Psychomotor Performance; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Retinopathy of Prematurity | 1995 |
Outcome at 1-year adjusted age of 957 infants weighing more than 1250 grams with respiratory distress syndrome randomized to receive synthetic surfactant or air placebo. American and Canadian Exosurf Neonatal Study Groups.
Topics: Air; Child Development; Chronic Disease; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Humans; Infant, Low Birth Weight; Infant, Newborn; Lung Diseases; Male; Nervous System Diseases; Phosphorylcholine; Polyethylene Glycols; Psychomotor Performance; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1995 |
Double-blind, randomized, placebo-controlled Canadian multicenter trial of two doses of synthetic surfactant or air placebo in 224 infants weighing 500 to 749 grams with respiratory distress syndrome. Canadian Exosurf Neonatal Study Group.
Topics: Air; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Male; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Survival Rate | 1995 |
Effects of two rescue doses of synthetic surfactant in 344 infants with respiratory distress syndrome weighing 750 to 1249 grams: a double-blind, placebo-controlled multicenter Canadian trial. Canadian Exosurf Neonatal Study Group.
Topics: Air; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Newborn; Lung Diseases; Male; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1995 |
Double-blind, randomized trial of one versus three prophylactic doses of synthetic surfactant in 826 neonates weighing 700 to 1100 grams: effects on mortality rate. American Exosurf Neonatal Study Groups I and IIa.
Topics: Bronchopulmonary Dysplasia; Cause of Death; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Enterocolitis, Pseudomembranous; Fatty Alcohols; Follow-Up Studies; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature, Diseases; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn | 1995 |
Instillation rate effects of Exosurf on cerebral and cardiovascular haemodynamics in preterm neonates.
Topics: Blood Flow Velocity; Blood Pressure; Brain; Cerebrovascular Circulation; Drug Administration Schedule; Drug Combinations; Fatty Alcohols; Female; Heart; Hemodynamics; Humans; Infant, Newborn; Infant, Premature; Instillation, Drug; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1994 |
Improved oxygenation during synchronized intermittent mandatory ventilation in neonates with respiratory distress syndrome: a randomized, crossover study.
Topics: Carbon Dioxide; Combined Modality Therapy; Cross-Over Studies; Drug Combinations; Fatty Alcohols; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Intermittent Positive-Pressure Ventilation; Oxygen; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Treatment Outcome | 1995 |
Partial liquid ventilation in premature lambs with respiratory distress syndrome: efficacy and compatibility with exogenous surfactant.
Topics: Animals; Animals, Newborn; Biological Products; Combined Modality Therapy; Drug Combinations; Emulsions; Fatty Alcohols; Fluorocarbons; Humans; Hydrocarbons, Brominated; Infant, Newborn; Oxygen; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Pulmonary Surfactants; Random Allocation; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Sheep | 1995 |
Pulmonary mechanics in ventilated preterm infants with respiratory distress syndrome after exogenous surfactant administration: a comparison between two surfactant preparations.
Topics: Airway Resistance; Biological Products; Combined Modality Therapy; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Humans; Infant, Newborn; Infant, Premature, Diseases; Lung Compliance; Male; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Positive-Pressure Respiration; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Respiratory Mechanics; Time Factors | 1994 |
Exosurf rescue surfactant improves high ventilation-perfusion mismatch in respiratory distress syndrome.
Topics: Airway Resistance; Blood Gas Analysis; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Newborn; Male; Oxygen Consumption; Phosphorylcholine; Polyethylene Glycols; Pulmonary Circulation; Pulmonary Gas Exchange; Pulmonary Surfactants; Regression Analysis; Respiration; Respiratory Distress Syndrome, Newborn; Time Factors | 1994 |
Surfactant therapy in respiratory distress syndrome--the first local experience.
Topics: Cause of Death; Combined Modality Therapy; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Newborn; Length of Stay; Male; Oxygen Inhalation Therapy; Phosphorylcholine; Pilot Projects; Polyethylene Glycols; Prospective Studies; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Survival Rate; Treatment Outcome | 1994 |
OSIRIS trial.
Topics: Adrenal Cortex Hormones; Drug Administration Schedule; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1993 |
OSIRIS trial.
Topics: Brain Diseases; Drug Administration Schedule; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Ultrasonography | 1993 |
OSIRIS trial.
Topics: Drug Administration Schedule; Drug Combinations; Fatty Alcohols; Humans; Infant Mortality; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1993 |
OSIRIS trial.
Topics: Diagnostic Errors; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Radiography; Respiratory Distress Syndrome, Newborn | 1993 |
Static respiratory compliance in the newborn. III: Early changes after exogenous surfactant treatment.
Topics: Animals; Biological Products; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Newborn; Infant, Premature; Lung Compliance; Male; Oxygen; Partial Pressure; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Swine | 1994 |
Comparison of clinical responses to natural and synthetic surfactants.
Topics: Arteries; Biological Products; Cerebral Hemorrhage; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Oxygen; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pulmonary Alveoli; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn | 1993 |
Modified bovine surfactant (Survanta) versus a protein-free surfactant (Exosurf) in the treatment of respiratory distress syndrome in preterm infants: a pilot study.
Topics: Biological Products; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Newborn; Infant, Premature; Male; Phosphorylcholine; Pilot Projects; Polyethylene Glycols; Prospective Studies; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1994 |
Respiratory distress syndrome in New Zealand: evidence from the OSIRIS trial of exogenous surfactant (Exosurf).
Topics: Birth Weight; Cerebral Hemorrhage; Cohort Studies; Cost of Illness; Drug Combinations; Fatty Alcohols; Female; Hospital Mortality; Humans; Infant, Newborn; Infant, Premature; Male; New Zealand; Oxygen Inhalation Therapy; Phosphorylcholine; Polyethylene Glycols; Prenatal Care; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Steroids; Survival Rate; Ultrasonography | 1994 |
Cardiorespiratory and stress hormone responses during first dose surfactant administration in neonates with RDS.
Topics: Biological Products; Blood Pressure; Catecholamines; Drug Combinations; Fatty Alcohols; Hemodynamics; Humans; Infant, Newborn; Oxygen; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Sympathetic Nervous System | 1994 |
A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. National Institute of Child Health and Human Development Neonatal Research Network.
Topics: Biological Products; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Newborn; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Respiratory Mechanics; Treatment Outcome | 1993 |
Cost effects of surfactant therapy for neonatal respiratory distress syndrome.
Topics: Costs and Cost Analysis; Drug Combinations; Fatty Alcohols; Female; Hospital Costs; Hospital Mortality; Humans; Infant, Newborn; Infant, Premature; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Regression Analysis; Respiratory Distress Syndrome, Newborn | 1993 |
[Natural and synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
Topics: Biological Products; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Infant, Premature, Diseases; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1994 |
Long-term pulmonary consequences of respiratory distress syndrome in preterm infants treated with exogenous surfactant.
Topics: Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Humans; Infant, Newborn; Infant, Premature; Lung Diseases; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Respiratory Function Tests; Treatment Outcome | 1993 |
A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.
Topics: Biological Products; Chronic Disease; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Lung Diseases; Male; Oxygen Inhalation Therapy; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Risk | 1996 |
Retinopathy of prematurity in a controlled trial of prophylactic surfactant treatment.
Topics: Drug Combinations; England; Fatty Alcohols; Female; Follow-Up Studies; Humans; Incidence; Infant, Newborn; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Retinopathy of Prematurity; Survival Analysis | 1996 |
Exogenous surfactant use in neonates.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Biological Products; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1996 |
A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome.
Topics: Bronchopulmonary Dysplasia; Cross-Over Studies; Drug Combinations; Fatty Alcohols; Humans; Incidence; Infant, Newborn; Length of Stay; Linear Models; Phosphorylcholine; Pneumothorax; Polyethylene Glycols; Pulmonary Emphysema; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Survival Rate; Time Factors; Treatment Outcome | 1996 |
Factors affecting the neonatal response to artificial surfactant.
Topics: Administration, Inhalation; Analysis of Variance; Chi-Square Distribution; Drug Combinations; Evaluation Studies as Topic; Fatty Alcohols; Female; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Male; Oxygen Consumption; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiration; Respiratory Distress Syndrome, Newborn; Survival Rate; Treatment Outcome | 1996 |
Comparison of the changes in the a/A oxygen ratio after administration of two surfactants for the treatment of neonatal respiratory distress syndrome.
Topics: Algorithms; Biological Products; Blood Gas Analysis; Drug Combinations; Fatty Alcohols; Humans; Hypoxia; Infant, Newborn; Infant, Premature; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1997 |
A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.
Topics: Age Factors; Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Data Interpretation, Statistical; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Newborn; Linear Models; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Time Factors; Treatment Outcome | 1997 |
Surfactant replacement therapy improves ventilation inhomogeneity in infants with respiratory distress syndrome.
Topics: Analysis of Variance; Biological Products; Breath Tests; Double-Blind Method; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Linear Models; Nitrogen; Phosphorylcholine; Polyethylene Glycols; Positive-Pressure Respiration; Pulmonary Gas Exchange; Pulmonary Surfactants; Pulmonary Ventilation; Respiratory Distress Syndrome, Newborn | 1997 |
Collaborative trial of prenatal thyrotropin-releasing hormone and corticosteroids for prevention of respiratory distress syndrome. Collaborative Santiago Surfactant Group.
Topics: Adrenal Cortex Hormones; Adult; Betamethasone; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Fetus; Humans; Incidence; Infant, Newborn; Injections, Intramuscular; Injections, Intravenous; Maternal Welfare; Phosphorylcholine; Polyethylene Glycols; Pregnancy; Pregnancy Outcome; Prolactin; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Thyroid Hormones; Thyrotropin-Releasing Hormone | 1998 |
Changes in pulmonary artery pressure during the acute phase of respiratory distress syndrome treated with three different types of surfactant.
Topics: Acceleration; Biological Products; Birth Weight; Blood Pressure; Cardiac Output; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Inhalation; Oxygen; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pressure; Pulmonary Artery; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Time Factors; Ultrasonography, Doppler; Ventricular Function, Right | 1998 |
Randomized trial examining cerebral haemodynamics following artificial or animal surfactant.
Topics: Biological Products; Cerebral Arteries; Cerebrovascular Circulation; Drug Combinations; Fatty Alcohols; Hemodynamics; Humans; Infant, Newborn; Infant, Premature; Intermittent Positive-Pressure Ventilation; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Regional Blood Flow; Respiratory Distress Syndrome, Newborn; Statistics, Nonparametric | 1998 |
Serial phospholipid analysis in preterm infants: comparison of Exosurf and Survanta.
Topics: Analysis of Variance; Biological Products; Chi-Square Distribution; Chromatography, Thin Layer; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Newborn; Infant, Premature; Male; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Treatment Outcome | 1999 |
Single dose surfactant rescue therapy in neonatal respiratory distress syndrome.
Topics: Biological Products; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Newborn; Lipids; Male; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Survival Analysis | 1998 |
Comparative trial of artificial and natural surfactants in the treatment of respiratory distress syndrome of prematurity: experiences in a developing country.
Topics: Biological Products; Blood Gas Analysis; Developing Countries; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Male; Oman; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Retrospective Studies; Survival Rate; Treatment Outcome | 1999 |
Randomized trial comparing natural and synthetic surfactant: increased infection rate after natural surfactant?
Topics: Biological Products; C-Reactive Protein; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Newborn; Infant, Premature; Leukopenia; Male; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Risk; Sepsis; Thrombocytopenia | 2000 |
The effects of synthetic and natural surfactant on fluid balance in acute respiratory distress syndrome.
Topics: Biological Products; Birth Weight; Diuresis; Drug Combinations; Fatty Alcohols; Gestational Age; Humans; Infant, Newborn; Infant, Premature; London; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Time Factors; Treatment Outcome; Water-Electrolyte Balance | 2000 |
Comparative randomized study: administration of natural and synthetic surfactant to premature newborns with respiratory distress syndrome.
Topics: Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Infant, Premature; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn | 2002 |
Early or selective surfactant (colfosceril palmitate, Exosurf) for intubated babies at 26 to 29 weeks gestation. A European double-blind trial with sequential analysis. European Exosurf Study Group.
Topics: Brain Diseases; Cysts; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Fatty Alcohols; Female; Gestational Age; Humans; Hydrocephalus; Infant, Newborn; Infant, Premature; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Treatment Outcome; Ultrasonography | 1992 |
Early versus delayed neonatal administration of a synthetic surfactant--the judgment of OSIRIS. The OSIRIS Collaborative Group (open study of infants at high risk of or with respiratory insufficiency--the role of surfactant.
Topics: Drug Administration Schedule; Drug Combinations; Fatty Alcohols; Humans; Infant; Infant, Newborn; Oxygen Consumption; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Risk Factors; Treatment Outcome | 1992 |
Surfactant for babies.
Topics: Drug Administration Schedule; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1992 |
Exosurf treatment investigational new drug phase: effect of an individualized third dose in infants with respiratory distress syndrome.
Topics: Drug Administration Schedule; Drug Combinations; Drugs, Investigational; Fatty Alcohols; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Retrospective Studies | 1992 |
Mucus rheology and transport in neonatal respiratory distress syndrome and the effect of surfactant therapy.
Topics: Drug Combinations; Elasticity; Fatty Alcohols; Humans; Infant, Newborn; Infant, Premature; Mucociliary Clearance; Mucus; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Rheology; Viscosity | 1992 |
Turnover of exogenous artificial surfactant.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Birth Weight; Chromatography, High Pressure Liquid; Drug Combinations; Fatty Alcohols; Gestational Age; Humans; Infant, Newborn; Intubation, Intratracheal; Phosphatidylcholines; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1992 |
Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Double-Blind Method; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1991 |
Pulmonary mechanics and energetics in preterm infants who had respiratory distress syndrome treated with synthetic surfactant.
Topics: Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Infant, Premature; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Respiratory Function Tests; Respiratory Mechanics | 1992 |
Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 grams. The American Exosurf Neonatal Study Group I.
Topics: Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Double-Blind Method; Drug Combinations; Ductus Arteriosus, Patent; Fatty Alcohols; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Survival Analysis | 1992 |
Energy expenditure during synthetic surfactant replacement therapy for neonatal respiratory distress syndrome.
Topics: Calorimetry, Indirect; Drug Combinations; Energy Metabolism; Fatty Alcohols; Humans; Infant, Low Birth Weight; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1992 |
Elastase activity and surfactant protein concentration in tracheal aspirates from neonates receiving synthetic surfactant.
Topics: Drug Combinations; Fatty Alcohols; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Pancreatic Elastase; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Trachea | 1992 |
Pulmonary hemorrhage in premature infants after treatment with synthetic surfactant: an autopsy evaluation. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
Topics: Autopsy; Double-Blind Method; Drug Combinations; Fatty Alcohols; Hemorrhage; Humans; Incidence; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Lung Diseases; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1992 |
A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
Topics: Birth Weight; Bronchopulmonary Dysplasia; Child; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Humans; Infant, Newborn; Infant, Premature, Diseases; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Ventilator Weaning | 1991 |
Reduced mortality in small premature infants treated at birth with a single dose of synthetic surfactant.
Topics: Bronchopulmonary Dysplasia; Drug Combinations; Fatty Alcohols; Follow-Up Studies; Humans; Incidence; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1991 |
Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: a multicenter controlled trial. American Exosurf Pediatric Study Group 1.
Topics: Bronchopulmonary Dysplasia; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Newborn; Infant, Premature; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Survival Rate | 1991 |
Cerebral blood flow velocity after surfactant instillation in preterm infants.
Topics: Blood Flow Velocity; Cerebral Hemorrhage; Cerebrovascular Circulation; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Infant, Premature; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1991 |
Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.
Topics: Bronchopulmonary Dysplasia; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Fatty Alcohols; Humans; Infant, Low Birth Weight; Infant, Newborn; Outcome and Process Assessment, Health Care; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1991 |
Improved outcome at 28 days of age for very low birth weight infants treated with a single dose of a synthetic surfactant.
Topics: Bronchopulmonary Dysplasia; Cause of Death; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Humans; Incidence; Infant, Low Birth Weight; Infant, Newborn; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Survival Rate | 1990 |
30 other study(ies) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Infantile Respiratory Distress Syndrome
Article | Year |
---|---|
Indomethacin pharmacodynamics are altered by surfactant: a possible challenge to current indomethacin dosing guidelines created before surfactant availability.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Biological Products; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Interactions; Ductus Arteriosus, Patent; Echocardiography; Echocardiography, Doppler, Color; Fatty Alcohols; Guideline Adherence; Humans; Indomethacin; Infant, Newborn; Intensive Care Units, Neonatal; Kidney; Metabolic Clearance Rate; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 2010 |
Respiratory distress syndrome in VLBW infants: changes in management and outcomes observed by the NICHD Neonatal Research Network.
Topics: Adrenal Cortex Hormones; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; National Institutes of Health (U.S.); Oxygen; Phosphorylcholine; Polyethylene Glycols; Pregnancy; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Treatment Outcome; United States | 2003 |
An observational study of surfactant treatment in infants of 23-30 weeks' gestation: comparison of prophylaxis and early rescue.
Topics: Biological Products; Drug Administration Schedule; Drug Combinations; Fatty Alcohols; Gestational Age; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Italy; Lipids; Oxygen Inhalation Therapy; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Retrospective Studies; Time Factors; Treatment Outcome | 2003 |
[Biophysical models in investigations of exogenous surfactant activities on the surface tension and their theurapeutic effectiveness].
Topics: Animals; Biological Products; Biophysical Phenomena; Biophysics; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Lipids; Models, Biological; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Surface Tension | 2007 |
Changes in pulmonary artery pressure in infants with respiratory distress syndrome following treatment with Exosurf.
Topics: Acute Disease; Blood Pressure; Drug Combinations; Echocardiography, Doppler; Fatty Alcohols; Humans; Infant, Newborn; Infant, Premature; Phosphorylcholine; Polyethylene Glycols; Pulmonary Artery; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1995 |
Acute effects of synthetic surfactant replacement on pulmonary blood flow in neonatal respiratory distress syndrome.
Topics: Blood Flow Velocity; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Newborn; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Circulation; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Suction; Ultrasonography, Doppler | 1994 |
Outcome of infants with birth weights less than 1000 g with respiratory distress syndrome treated with high-frequency ventilation and surfactant replacement therapy.
Topics: Biological Products; Combined Modality Therapy; Drug Combinations; Fatty Alcohols; High-Frequency Ventilation; Humans; Infant, Low Birth Weight; Infant, Newborn; Logistic Models; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Retrospective Studies; Treatment Outcome | 1995 |
Pulmonary hemorrhage risk in infants with a clinically diagnosed patent ductus arteriosus: a retrospective cohort study.
Topics: Cohort Studies; Drug Combinations; Ductus Arteriosus, Patent; Fatty Alcohols; Female; Hemorrhage; Humans; Infant, Newborn; Lung Diseases; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Retrospective Studies | 1994 |
Platelet-activating factor in surfactant preparations.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Biological Products; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phospholipases A; Phospholipids; Phosphorylcholine; Platelet Activating Factor; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Trachea | 1993 |
[Natural or synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
Topics: Biological Products; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Newborn; Male; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1994 |
Efficacy of surfactant therapy in infants managed with CPAP.
Topics: Combined Modality Therapy; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Newborn; Male; Phosphorylcholine; Polyethylene Glycols; Positive-Pressure Respiration; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1995 |
[Outcome of blood gas parameters during the first 24 years after Exosurf administration].
Topics: Analysis of Variance; Blood Gas Analysis; Cohort Studies; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Infant, Premature; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Time Factors | 1996 |
Changes in pulmonary artery pressure in infants with respiratory distress syndrome after treatment with Exosurf.
Topics: Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Infant, Premature; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Pulmonary Wedge Pressure; Respiratory Distress Syndrome, Newborn | 1996 |
Costs and outcomes associated with colfosceril versus beractant for the treatment of neonatal respiratory distress syndrome.
Topics: Biological Products; Drug Combinations; Drug Costs; Fatty Alcohols; Humans; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Treatment Outcome | 1997 |
Nebulisation of surfactants in an animal model of neonatal respiratory distress.
Topics: Aerosols; Animals; Biological Products; Carbon Dioxide; Disease Models, Animal; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Lung; Nebulizers and Vaporizers; Oxygen; Partial Pressure; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Rabbits; Respiratory Distress Syndrome, Newborn | 1998 |
First intention high-frequency oscillation with early lung volume optimization improves pulmonary outcome in very low birth weight infants with respiratory distress syndrome.
Topics: Drug Combinations; Fatty Alcohols; Female; High-Frequency Ventilation; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Treatment Outcome | 2000 |
Randomized trial comparing natural and synthetic surfactant: increased infection rate after natural surfactant?
Topics: Biological Products; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Infant, Premature; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Randomized Controlled Trials as Topic; Respiratory Distress Syndrome, Newborn; Risk; Sepsis | 2000 |
Current surfactant use in premature infants.
Topics: Drug Combinations; Fatty Alcohols; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Treatment Outcome | 2001 |
[Exosurf-Neonatal: the synthetic surfactant. Introductory symposium, 20 June 1992].
Topics: Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1992 |
Effect of intra-amniotic administration of Exosurf in preterm rabbit fetuses.
Topics: Amnion; Animals; Animals, Newborn; Drug Combinations; Fatty Alcohols; Fetus; Gestational Age; Humans; Infant, Newborn; Injections; Lung; Organ Size; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Rabbits; Respiratory Distress Syndrome, Newborn | 1992 |
Criteria for use of colfosceril (Exosurf) in neonates.
Topics: Apnea; Drug Combinations; Fatty Alcohols; Hemorrhage; Humans; Infant, Newborn; Intubation, Intratracheal; Lung Diseases; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn | 1992 |
A controlled clinical comparison of four different surfactant preparations in surfactant-deficient preterm lambs.
Topics: Animals; Animals, Newborn; Biological Products; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Sheep | 1992 |
Prediction of the acute response to surfactant therapy by pulmonary function testing.
Topics: Airway Resistance; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Lung Compliance; Phosphorylcholine; Polyethylene Glycols; Predictive Value of Tests; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Respiratory Function Tests | 1992 |
Surfactant replacement therapy: issues related to currently available preparations.
Topics: Biological Products; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Infant, Premature; Maternal-Child Nursing; Monitoring, Physiologic; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1992 |
Comparing surfactant products.
Topics: Biological Products; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1991 |
Synthetic vs human surfactants in the treatment of respiratory distress syndrome: radiographic findings.
Topics: Bronchopulmonary Dysplasia; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Emphysema; Pulmonary Surfactants; Radiography, Thoracic; Respiratory Distress Syndrome, Newborn | 1991 |
Colfosceril palmitate (Exosurf)--artificial surfactant for immature lungs.
Topics: Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1991 |
From the Food and Drug Administration.
Topics: Chronic Disease; Diet Fads; Dietary Fiber; Drug Combinations; Esophageal Stenosis; Fatty Alcohols; Fentanyl; Galactans; Humans; Infant, Low Birth Weight; Infant, Newborn; Mannans; Pain; Phosphorylcholine; Plant Gums; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; United States; United States Food and Drug Administration | 1990 |
Lung function in prematurely delivered rabbits treated with a synthetic surfactant.
Topics: Animals; Drug Combinations; Fatty Alcohols; Infant, Newborn; Lung; Lung Compliance; Lung Volume Measurements; Phosphorylcholine; Polyethylene Glycols; Positive-Pressure Respiration; Pulmonary Gas Exchange; Pulmonary Surfactants; Rabbits; Respiratory Distress Syndrome, Newborn | 1987 |
Effects of a protein-free, synthetic surfactant on survival and pulmonary function in preterm lambs.
Topics: Animals; Animals, Newborn; Drug Combinations; Fatty Alcohols; Fetal Organ Maturity; Humans; Infant, Newborn; Lung; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Sheep | 1985 |